跳至主要内容
临床试验/CTIS2022-503010-23-01
CTIS2022-503010-23-01进行中(未招募)1 期

Cluster and Registry trial Of the Working group of heart failure in Denmark. Are CarvedilOl and Metoprolol succinate comPArable treatments in heart failure patients with Reduced Ejection fraction. - English

Odense University Hospital0 个研究点目标入组 5,600 人开始时间: 2023年3月8日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
5,600

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

年龄范围
18 至 65+(—)
性别
All

入选标准

  • Patients who are registered in the Danish Heart Failure Registry with reduced ejection fraction who have claimed at least one prescription for either Carvedilol or Metoprolol succinate.

排除标准

  • Patients who have filled in a prescription for Carvedilol or Metoprolol succinate before the date of first registered visit in the Danish Heart Failure Registry and patients who have opted out of the study

研究者

相似试验